CAR-T Cell Therapy in Solid Tumor

Abstract

Chimeric antigen receptor (CAR) T cell immunotherapy has gained significant popularity in recent years as a promising approach for cancer treatment. This form of immunotherapy involves the genetic modification of T cells to enable them to recognize and attack cancer cells within the body. Despite the advancements in CAR-T cell therapy and related technologies, several challenges persist in the field of solid tumor research. These challenges include antigen escape, off-target effects, and the complex immune microenvironment. This study aims to evaluate the advantages and drawbacks of CAR-T cell therapy specifically in the context of solid tumors, shedding light on potential avenues for further development. Furthermore, the application of CAR-T cell treatment in solid tumors, such as breast cancer, is discussed. The study also addresses various limitations associated with CAR-T cell therapy, including the influence of the immune microenvironment and the potential for antigen evasion. In addition, the study explores future directions for CAR-T cell therapy, highlighting the potential role of synthetic biology. By examining these aspects, this research aims to contribute to the understanding of CAR-T cell treatment and provide valuable insights to combat solid tumors effectively.